{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:15:25Z","timestamp":1778238925976,"version":"3.51.4"},"reference-count":48,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"u.s. food and drug administration","doi-asserted-by":"publisher","award":["75F40121C00120"],"award-info":[{"award-number":["75F40121C00120"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical and Translational Research Institute","award":["1 UL1 RR024140 01"],"award-info":[{"award-number":["1 UL1 RR024140 01"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Respir Dis"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic lung infection associated with persistent respiratory symptoms and diminished health-related quality of life (HRQoL). As with other chronic conditions, increased levels of anxiety and depression can impact prognosis and HRQoL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To describe the prevalence of anxiety and depression and to identify HRQoL domains that are correlated with mental health in patients with NTM-PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A cross-sectional observational study of adults with self-reported or clinically confirmed NTM-PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Participants with NTM-PD enrolled in two studies (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200940 interview + surveys and\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u2009230 completing electronic surveys only) at four U.S. sites. Inclusion criteria were age &gt;18\u2009years, English-speaking, and U.S. residence. In-person enrolled participants met ATS\/IDSA criteria and had symptom documentation in medical records; remotely enrolled participants self-reported NTM-PD and symptoms. Data collected included demographics, GAD-7 and PHQ-8 (anxiety and depression screening, respectively), QOL-B Respiratory Symptoms Scale (RSS), selected PROMIS short forms (Fatigue 7a, Cognitive Function 6a, Sleep Disturbance 4a), and Patient Global Impression of Severity of NTM-PD symptoms (PGIS). Interview-only participants completed the GAD-7, PHQ-8, QOL-B RSS, and were evaluated for cognitive functioning using the computerized Symbol Digit Modalities Test (oral version).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study population was predominantly female (57%\/91% in the interview\/survey studies, respectively) and aged &gt;65\u2009years (50%\/77.4%). Overall, 18%\/14% screened positive for anxiety and 32%\/18% for depression. Participants screening positive for anxiety or depression had significantly lower QOL-B RSS, cognitive function, and sleep scores, and higher fatigue. Fatigue showed the strongest correlation with mental health outcomes, particularly with those screening positive for depression (\n                      <jats:italic toggle=\"yes\">\u03c1<\/jats:italic>\n                      \u2009=\u20090.644,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Mental health symptoms are strongly correlated with worse HRQoL outcomes in NTM-PD. These findings underscore the need for the implementation of routine mental health screening and interventions in NTM-PD care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17534666251396240","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T08:17:06Z","timestamp":1763799426000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["The association between mental health, cognitive functioning, and health-related quality of life in adults with chronic nontuberculous mycobacterial pulmonary disease"],"prefix":"10.1177","volume":"19","author":[{"given":"Madysen","family":"Schreiber","sequence":"first","affiliation":[{"name":"OHSU-PSU School of Public Health, Oregon Health &amp; Science University, Portland, OR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra L.","family":"Quittner","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis, Pulmonary Medicine and Sleep Center, Joe DiMaggio Children\u2019s Hospital, Hollywood, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5190-9383","authenticated-orcid":false,"given":"Emily","family":"Henkle","sequence":"additional","affiliation":[{"name":"OHSU-PSU School of Public Health, Oregon Health &amp; Science University, 1810 SW 5th Ave, suite 510, Portland, OR 97232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201412-559OC"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201002-0310OC"},{"key":"e_1_3_4_5_2","unstructured":"U.S. Food and Drug Administration Center for Drug Evaluation and Research. A series of reports from the FDA\u2019s Patient-Focused Drug Development Initiative. Public Meeting http:\/\/www.fda.gov\/ForIndustry\/UserFees\/PrescriptionDrugUserFee\/ucm326192.htm (accessed 15 October 2015)."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.17.0433"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.08.004"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.04.166"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-1165-3"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2021.1987891"},{"key":"e_1_3_4_11_2","volume-title":"World mental health report: Transforming mental health for all","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. World mental health report: Transforming mental health for all. 1st ed. Geneva: World Health Organization, 2022.","edition":"1"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00007813"},{"key":"e_1_3_4_13_2","article-title":"Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis","volume":"12","author":"Lee YJ","year":"2017","unstructured":"Lee YJ, Choi SM, Lee YJ, et al. Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis. PLoS ONE 2017; 12: e0184300.","journal-title":"PLoS ONE"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-020-00281-8"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205983"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201605-387WS"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00574-2020"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/13548506.2020.1808235"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181577511"},{"key":"e_1_3_4_22_2","unstructured":"Henkle E Megson G Daley CL et al. Development of a nontuberculous mycobacterial symptom Scale (NTM-SS): phase I qualitative interviews. [abstract] Int Soc Qual of Life Res 2023. https:\/\/www.isoqol.org\/wp-content\/uploads\/2023\/09\/0.-Final-Program_OBP_2023.pdf"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517690821"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.acn.2005.07.003"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518808204"},{"key":"e_1_3_4_26_2","first-page":"275","volume-title":"ERS International Congress 2015","author":"Quittner AL","unstructured":"Quittner AL, Madan A, Saez-Flores E. Development of a quality of life measure for nontuberculous mycobacteria (NTM) [abstract]. ERS International Congress 2015, Amsterdam, Netherlands, p. 275."},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205918"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01300-2019"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202405-457OC"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2010.08.033"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3522"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/15402002.2012.636266"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2004.00301.x"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.01.018"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49488"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48276-1"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/arm91020011"},{"key":"e_1_3_4_38_2","article-title":"Prevalence and clinical characteristics of anxiety and depression in patients non-CF bronchiectasis: a single-center, cross-sectional study","author":"Niknafs A","unstructured":"Niknafs A, Blakney RA, Goldstein D, et al. Prevalence and clinical characteristics of anxiety and depression in patients non-CF bronchiectasis: a single-center, cross-sectional study. [abstract] American Thoracic Society 2021 (virtual) AJRCCM A1565-A1565.","journal-title":"AJRCCM"},{"key":"e_1_3_4_39_2","first-page":"211","volume-title":"Bronchiectasis","author":"Quittner AL","unstructured":"Quittner AL, Varley CD, Henkle E. Non-CF bronchiectasis and nontuberculous mycobacteria: integration of mental health and quality of life into patient care. In: Teneback CC, Garcia B (eds) Bronchiectasis. Cham: Springer International Publishing, pp. 211\u2013233."},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-025-03553-9"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.06.006"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.17-0840"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207488"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2006.11.005"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.07.020"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.24949"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinme.2024.100017"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0134"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.09.014"}],"container-title":["Therapeutic Advances in Respiratory Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17534666251396240","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17534666251396240","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17534666251396240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T08:07:16Z","timestamp":1764144436000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17534666251396240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":48,"alternative-id":["10.1177\/17534666251396240"],"URL":"https:\/\/doi.org\/10.1177\/17534666251396240","relation":{"has-review":[{"id-type":"doi","id":"10.1177\/17534666251396240\/v4\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251396240\/v4\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251396240\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251396240\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251396240\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251396240\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251396240\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251396240\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251396240\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251396240\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/17534666251396240\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1753-4666","1753-4666"],"issn-type":[{"value":"1753-4666","type":"print"},{"value":"1753-4666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"article-number":"17534666251396240"}}